Palantir Technologies Inc. held its first Developer Conference, DevCon, November 13th-14th, 2024. This exclusive conference brought together 150 of the most ambitious commercial and government ...
During the three months ended September 30, 2024, the Company sold, under the Open Market Sale Agreement with Jefferies LLC, ...
IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program; ACE1831 is an allogeneic gamma delta T cell therapy candidate targetin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback